KK
Kristen Kluska Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
55
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90.9%
Neutral
9.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $153 |
70%
upside
| 1 | +33% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Overweight
Maintained
| $63 |
26%
upside
| 2 | +16% |
0
%
| 30 Sep ‘25 19 days ago |
|
|
|
Overweight
Maintained
| $80 |
38%
upside
| 1 | +198% |
0
%
| 25 Sep ‘25 24 days ago |
|
|
|
Overweight
Reiterated
| $105 |
222%
upside
| 2 | -7.1% |
0
%
| 5 Sep ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $118 |
79%
upside
| 2 | +11% |
0
%
| 3 Sep ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $74 |
8%
downside
| 1 | +69% |
0
%
| 27 Aug ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $32 |
15%
upside
| 1 | – |
–
| 6 Aug ‘25 2 months ago |
|
|
|
Overweight
Initiated
| $11 |
90%
upside
| 1 | +14% |
0
%
| 24 Jul ‘25 2 months ago |
|